Income Taxes (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Summary of Income (Loss) Before Income Taxes On Continuing Operations

The domestic and foreign components of (loss) income before provision for income taxes on continuing operations were as follows:

	2023		2022		2021
Domestic	$	(63,874)	$	(131,717)	$	1,348
Foreign	5,144		(6,063)		(227)
Total (loss) income before income taxes	$	(58,730)	$	(137,780)	$	1,121

Schedule of Provision (Benefit) for Income Taxes On Continuing Operations

The provision (benefit) for income taxes on continuing operations consisted of the following:

	Year Ended December 31,
	2023		2022		2021
Current (benefit) / provision
Federal	$	—	$	2	$	(16)
State	92		77		126
Foreign	(1,689)		2,756		1,666
Total current (benefit) / provision	$	(1,597)	$	2,835	$	1,776
Deferred (benefit) / provision
Federal	$	3	$	733	$	(2,300)
State	(4)		197		239
Foreign	3,200		(1,062)		(2,464)
Total deferred (benefit) / provision	$	3,199	$	(132)	$	(4,525)
Total (benefit) / provision
Federal	$	3	$	735	$	(2,316)
State	88		274		365
Foreign	1,511		1,694		(798)
Total (benefit) / provision	$	1,602	$	2,703	$	(2,749)

Summary of Reconciliation of the U.S. Statutory Income Tax Rate On Continuing Operations to the Company's Effective Tax Rate

A reconciliation of the U.S. federal statutory income tax rate on continuing operations of 21% for the years ended December 31, 2023, 2022 and 2021 to the Company’s effective tax rate is as follows:

	Year Ended December 31,
	2023		2022		2021
Income tax (benefit) provision at the U.S. federal statutory rate	$	(12,333)	$	(28,934)	$	235
State income taxes	(1,418)		(1,208)		(454)
Permanent differences	(50)		380		286
Change in valuation allowance	11,725		14,529		4,693
Effect of foreign operations	1,837		(147)		(825)
Stock-based compensation	1,728		4,222		(838)
Transaction costs	—		—		1,247
Section 162(m)	221		493		—
Derivative and warrant liabilities	(36)		(1,940)		(6,612)
U.S. GILTI inclusion	511		139		—
Goodwill impairment	—		13,957		—
Effect of change in tax rates	17		(165)		(835)
Research & development tax credits	—		—		(501)
Foreign currency translation & transactions	(237)		560		254
Other	(363)		817		601
Total provision (benefit) for income taxes	$	1,602	$	2,703	$	(2,749)

Schedule of Deferred Tax Assets and Deferred Tax Liabilities

Significant components of deferred tax assets and liabilities as of were as follows:

	Year Ended December 31,
	2023		2022
Deferred tax assets
Net operating loss carryforwards	$	101,422	$	97,812
Accruals	2,119		2,295
Stock-based compensation	1,913		2,859
Bad debt	263		360
Interest expense	7,857		4,146
Lease liabilities	14,442		20,022
Section 174 capitalized R&D costs	13,057		9,826
Capitalized production expenses	330		2,384
Other	1,729		94
Total deferred tax asset	$	143,132	$	139,798
Valuation allowance	(116,404)		(104,679)
Net deferred tax asset	$	26,728	$	35,119
Deferred tax liabilities
Deferred state income tax	(3,158)		(2,678)
Operating lease, right-of-use asset	(11,334)		(16,078)
Depreciation and amortization	(710)		(1,529)
Intangible assets	(11,558)		(11,630)
Total deferred tax liability	$	(26,760)	$	(31,915)
Net deferred tax (liability) asset	$	(32)	$	3,204

Schedule of Income Tax Examinations

The earliest years’ tax returns filed by the Company that are still subject to examination by the tax authorities in the major jurisdictions are as follows:

	Years
United States	2019
United Kingdom	2022
Japan	2018
Canada	2019